← Back to All Filings

Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)

Medium SignificanceNovember 12, 2025 at 9:05:13 PM UTC

INDIVIOR PLC

$INVVYSCHEDULE 13G/ACIK: 0001625297

Subscribe to track INVVY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)

Company: INDIVIOR PLC (INVVY) Form: SCHEDULE 13G/A | Filed: 2025-11-12 Significance: Medium

Reporting Entity: THE GOLDMAN SACHS GROUP, INC. Relationship: Institutional Investor / >5% Owner

Holding Details: • Type: Statement of Passive Ownership • Security: Ordinary Shares • Shares Held: 6,531,869 • Stake: 5.2% of class

Key Insight: This filing amends Goldman Sachs' previously disclosed passive investment in the pharmaceutical company Indivior PLC, reaffirming their position as a significant institutional shareholder with a 5.2% stake.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: INDIVIOR PLC

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: Goldman Sachs Group filed a Schedule 13G/A, amending its reported passive ownership stake in Indivior PLC to 6,531,869 shares, representing 5.2% of the company's ordinary shares.
  • Market Impact: This filing reaffirms a significant, passive institutional position, which is generally a neutral to slightly positive signal of stability for the subject company, Indivior PLC.

Filing Information

FieldValue
Subject CompanyINDIVIOR PLC
Subject CIK0001625297
Ticker SymbolINVVY (ADR)
FilerTHE GOLDMAN SACHS GROUP, INC.
Filer CIK0000886982
Form TypeSCHEDULE 13G/A
Event Date2025-09-30

Ownership Details

FieldValue
Security TypeOrdinary shares, $0.50 nominal value per share
Shares Beneficially Owned6,531,868.75
Percent of Class5.2%
Shared Voting Power6,531,833.75
Shared Dispositive Power6,531,868.75
Nature of OwnershipPassive Investment (Not for control)

Financial Impact Assessment

Transaction Materiality

Note: The provided market data pertains to the filer (Goldman Sachs), not the subject company (Indivior PLC). Therefore, a quantitative analysis of the holding's value as a percentage of Indivior PLC's market capitalization cannot be performed.

Impact Evaluation

  • Ownership Concentration: Goldman Sachs holds a 5.2% stake, making it a significant institutional owner. Such a position can provide a degree of share price stability. As a passive stake (Rule 13d-1(b)), it indicates the investment is not intended to influence the control of Indivior PLC.
  • Institutional Conviction: This amended filing reaffirms Goldman Sachs' position in the specialty pharmaceutical company. While it's an amendment and not a new position, maintaining a stake above the 5% reporting threshold is a notable data point for investors tracking institutional money flow.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is an amendment to an existing passive holding, not a new purchase or activist campaign. It confirms the status quo of Goldman Sachs being a major shareholder, which is already known to the market. The filing itself is unlikely to cause significant price movement.

Volume & Sentiment

  • Expected Volume Impact: Low. Schedule 13G/A filings, especially from large institutions, are routine disclosures and rarely drive short-term trading volume.
  • Sentiment Indicator: Neutral. The filing confirms a large institution's continued passive investment, which can be viewed as a sign of stability, but it does not signal any new bullish or bearish catalyst.

Investment Insights

Key Takeaways

  1. Significant Institutional Stake: Goldman Sachs remains a major shareholder in Indivior PLC with a 5.2% passive stake.
  2. Passive Investment: The filing under Rule 13d-1(b) certifies that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
  3. Amendment Filing: This is an update (Amendment No. 2) to a previously reported position, not the initiation of a new stake, making it a routine disclosure.
Topics:#Schedule13G#InstitutionalOwnership#GoldmanSachs#Indivior#INVVY#SECfiling#StockMarket#Investing#Pharmaceuticals

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.